Outbreak of skin infections due to Staphylococcus aureus carrying Panton-Valentine leukocidin genes in pupils and their relatives;Épidémie d'infections cutanées à Staphylococcus aureus porteur des gènes codant la leucocidine de Panton-Valentine en milieu scolaire et familial

Medecine et Maladies Infectieuses

Volumn 41, Issue 7, 2011, Pages 364-371

  Carre N ^a   Herbreteau, N ^b   Askeur, N ^b   Dabas, J P ^c   F Sillam, ^b   Pinchon, C ^c   Bes, M ^d,e   Tristan, A ^d,e   Vandenesch, F ^d,e  

^a Cellule de l'InVS en région Ile de France ^*  (France)

^b Délégation territoriale du Val d'Oise   (France)

^c Centre hospitalier de Magny en Vexin   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

Family; Outbreak; Panton Valentine leukocidin; Pupils

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; EPIDEMIC; FOLLOW UP; FURUNCULOSIS; GENE IDENTIFICATION; HOUSEHOLD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL STUDENT; NONHUMAN; NOSE DISEASE; NURSERY SCHOOL; PATIENT MONITORING; PREVALENCE; PVL GENE; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN ABSCESS; SKIN INFECTION; STAPHYLOCOCCUS INFECTION;

ABSCESS; ADOLESCENT; ADULT; BACTERIAL TOXINS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; DISEASE OUTBREAKS; EXOTOXINS; FAMILY HEALTH; FEMALE; FOLLICULITIS; FRANCE; FURUNCULOSIS; HUMANS; HYGIENE; INCIDENCE; INFANT; LEUKOCIDINS; MALE; MASS SCREENING; MIDDLE AGED; NASAL CAVITY; RETROSPECTIVE STUDIES; SCHOOLS; SCHOOLS, NURSERY; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; STUDENTS; YOUNG ADULT;

EID: 79960914948     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2010.12.017     Document Type: Article

References (26)

1. Tristan A., Bes M., Meugnier H., et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2006, 13:594-600.
2. Dohin G., Gillet Y., Kohler R., et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007, 26:1042-1048.
3. Centers for disease control prevention Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999, 48:707-710.
4. Miller L.G., Diep B.A. Colonization, fomites, and virulence: rethinking the pathogenesis of community-associted mathicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008, 46:752-760.
5. Safdar N., Bradley E.A. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008, 121:310-315.
6. Nguyen D.M., Mascola L., Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 2005, 11:526-532.
7. Huijsdens X.W., van Lier A.M.C., van Kregten E., et al. Methicillin-resistant Staphylococcus aureus in Dutch soccer team. Emerg Infect Dis 2006, 12:1584-1586.
8. Centers for disease control and prevention (CDC) Methicillin-resistant Staphylococcus aureus infections in correctional facilities-Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003, 52:992-996.
9. Bagget H.C., Henessy T.W., Rudolph K., et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004, 189:1565-7153.
10. Wiese-Posselt M., Heuck D., Draeger A., et al. Successful termination of a furunculosis outbreak due to luks-lukf-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 2007, 44:88-95.
11. Lesens O., Haus-cheymol, Dubrous P., et al. Methicillin-susceptible doxycicline-resistant Staphylococcus aureus, Côte d'Ivoire. Emerg Infect Dis 2007, 12:488-490.
12. Boubaker K., Diebold P., Blanc D., et al. Panton-Valentine leukocidin and staphyloccoccal skin infections in children. Emerg Infect Dis 2004, 10:121-124.
13. Carré N., Sillam F., Dabas J.P., et al. Colonisation nasale et infections cutanées à Staphylococcus aureus porteur du gène codant la leucocidine de Panton-Valentine: dépistage lors d'une épidémie en milieu scolaire. Med Mal Infect 2008, 38:483-488.
14. Vandenesch F, Etienne J. Centre National de Référence des Staphylocoques. Rapport d'activités annuel 2006. http://dm3.univ-lyon1.fr.
15. Chambers H.F. Community-associated MRSA-resistance and virulence, coverage. Engl J N Med 2005, 352:1485-1487.
16. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
17. Fritz S.A., Epplin E.K., Garbutt J., Stroch G.A. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect 2009, 59:394-401.
18. Jones T.F., Creech C.B., Erwin P., Baird S.G., Woron A.M., Schaffner W. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006, 42:e76-78.
19. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 45:935-941.
20. Ellis M.W., Griffith M.E., Dooley D.P., et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 2007, 51:3591-3598.
21. Ammerlaan H.S.M., Kluytmans A.J.W., Wertheim H.F.L., Nouwen J.L., Bonten M.J.M. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
22. Recommandations sur la prise en charge et la prévention des infections cutanées liées aux souches de Staphylococcus aureus résistants à la méthicilline communautaires (sarm co). Commission spécialisée « sécurité des patients: infections nosocomiales et autres événements indésirables liés aux soins et aux pratiques ». Rapport du groupe de travail. Haut Conseil de la santé publique; décembre 2009.
23. Zetola N., Francis J.S., Nuemberger E.L., Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005, 5:275-286.
24. Bartels M.D., Boye K., Larsen A.R., skov R., Westh H. Rapid increase of genetically diverse methicillin-resistant Staphylococcus aureus, Copenhaguen, Denmark. Emerg Infect Dis 2007, 13:1533-1540.
25. Vourli S., Vagiakou H., Ganteris G. High rates of community-acquired Panton-Valentine leukocidin (PVL)-positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in Greece. Euro Surveill 2009, 14(2pii):19089.
26. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 4:227-239. [Review].